Clinical trial
A Randomized, Double-blind, Placebo-controlled Trial of Adjunctive Troriluzole in Obsessive Compulsive Disorder
NCT03299166 is registered in ClinicalTrials.gov with Biohaven Pharmaceuticals, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-blind, Placebo-controlled Trial of Adjunctive Troriluzole in Obsessive Compulsive Disorder
- Lead sponsor
- Biohaven Pharmaceuticals, Inc.
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- December 19, 2017
- Completion date
- December 8, 2025
- Enrollment
- 426 (actual)
- Sites
- 57
Conditions
As the registry lists them; a condition with its own page is linked.